skip banner - Return to original view
site viewing options
 
Parents|Medical Information|Professionals|In your area|Campaigns

Fabry disease

How is it treated

Until relatively recently the only treatments available for Fabry disease were symptomatic. Nerve pain is treated using anti-epileptic drugs such as gabapentin and carbamezapine; angiokeratomas may be removed or treated with laser therapy. Standard therapies such as aspirin, antihypertensives and anti-cholesterol agents are used to treat the renal, cardiovascular and cerebrovascular manifestations of the disease. More recently, the introduction of enzyme replacement therapy has offered the opportunity to treat the underlying cause of Fabry disease. Intravenous infusion of recombinant α-Gal A enzyme has been shown to clear deposists of GB3, stabilise renal function, reduce heart size and significantly improve pain scores and quality of life. Enzyme is administered intravenously every 2 weeks. In the UK most patients receive enzyme replacement at home.

View How is it diagnosed? How is it diagnosed?  |  Inheritance patterns and prenatal diagnosis View Inheritance patterns and prenatal diagnosis

Medical text written November 1991 by Contact a Family. Approved November 1991 by Professor M Patton, Professor of Medical Genetics, St Georges Hospital Medical School, London, UK and Dr J E Wraith, Consultant Paediatrician, Royal Manchester Children's Hospital, Manchester, UK. Last updated January 2008 by Dr Derralyn Hughes, Lecturer in Haematology, Royal Free and University College Medical School, London, UK.

 

Tell us what you think of this information...

Print whole article Print whole article

 

This Web Site © Copyright, Contact a Family 2008
Contact a Family, 209-211 City Road, London EC1V 1JN
Tel: (020) 7608 8700

Registered Charity No. 284912. Charity registered in Scotland No. SC039169
Company limited by guarantee, registered in England and Wales No. 1633333.
HM Revenue & Customs charity tax reference No. XN54769. VAT Reg. No. GB 749 3846 82